+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Clinical Trial Imaging Market Research Report by Product & Service (Services and Software), Modality, Therapeutic area, End-User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5470713
  • Report
  • April 2022
  • Region: Global
  • 198 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • anagram 4 clinical trials
  • Biospective Inc.
  • Calyx Group
  • Imaging Endpoints LI, LLC
  • IXICO plc.
  • Medpace Holdings, Inc.
The Global Clinical Trial Imaging Market size was estimated at USD 968.95 million in 2021, USD 1,035.32 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 7.02% to reach USD 1,456.34 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Clinical Trial Imaging to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product & Service, the market was studied across Services and Software. The Services is further studied across Operational Imaging Services, Read Analysis Services, System & Technical Support Services, and Trial Design & Consulting Services.
  • Based on Modality, the market was studied across Computed Tomography, Echocardiography, Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound, and X-ray.
  • Based on Therapeutic area, the market was studied across CVS, Endocrinology, Immunological Disorder, Infectious Diseases, Neurology, and Oncology.
  • Based on End-User, the market was studied across Academic & Government Research Institutes, Biotechnology Companies, Contract Research Organizations, Medical Device Manufacturer, and Pharmaceutical Companies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Clinical Trial Imaging market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Trial Imaging Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Clinical Trial Imaging Market, including anagram 4 clinical trials, BioClinica Inc., Biomedical Systems Corporation, Biospective Inc., BioTelemetry Inc., Boston Imaging Core Lab LLC., Calyx Group, Cardiovascular Imaging Technologies LLC., ICON plc., Imaging Endpoints LI, LLC, Intrinsic Imaging LLC., IXICO plc., Lyscaut Medical Imaging Company, Medical Metrics Inc., Medpace Holdings, Inc., Micron Inc., Parexel International Corporation, Perspectum Ltd., Pharmtrace klinische Entwicklung GmbH, Prism Clinical Imaging, Inc., ProScan Imaging LLC., Radiant Sage LLC., Resonance Health Ltd., and WorldCare Clinical, LLC.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Clinical Trial Imaging Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Clinical Trial Imaging Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Clinical Trial Imaging Market?
4. What is the competitive strategic window for opportunities in the Global Clinical Trial Imaging Market?
5. What are the technology trends and regulatory frameworks in the Global Clinical Trial Imaging Market?
6. What is the market share of the leading vendors in the Global Clinical Trial Imaging Market?
7. What modes and strategic moves are considered suitable for entering the Global Clinical Trial Imaging Market?
Frequently Asked Questions about the Global Clinical Trial Imaging Market

What is the estimated value of the Global Clinical Trial Imaging Market?

The Global Clinical Trial Imaging Market was estimated to be valued at $969.0 Million in 2021.

What is the growth rate of the Global Clinical Trial Imaging Market?

The growth rate of the Global Clinical Trial Imaging Market is 7.0%, with an estimated value of $1456.3 Million by 2027.

What is the forecasted size of the Global Clinical Trial Imaging Market?

The Global Clinical Trial Imaging Market is estimated to be worth $1456.3 Million by 2027.

Who are the key companies in the Global Clinical Trial Imaging Market?

Key companies in the Global Clinical Trial Imaging Market include anagram 4 clinical trials, BioClinica Inc., Biomedical Systems Corporation, Biospective Inc., BioTelemetry Inc., Boston Imaging Core Lab LLC., Calyx Group, Cardiovascular Imaging Technologies LLC. and Imaging Endpoints LI, LLC.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • anagram 4 clinical trials
  • Biospective Inc.
  • Calyx Group
  • Imaging Endpoints LI, LLC
  • IXICO plc.
  • Medpace Holdings, Inc.

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Significant investments made in drug development programs
5.1.1.2. Significant reduction in the drug development and approval timelines
5.1.1.3. A non-invasive method of study and usability when a biopsy is not possible
5.1.2. Restraints
5.1.2.1. Data security and privacy issues and possibility of misusing the images obtained for studies
5.1.3. Opportunities
5.1.3.1. Development of cloud-based platform simplifying the process of image sharing
5.1.3.2. Integration of artificial intelligence (AI) to minimize errors and maximize efficiency
5.1.4. Challenges
5.1.4.1. High cost associated with the imaging techniques and potential exposure to prohibitive radiation
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Clinical Trial Imaging Market, by Product & Service
6.1. Introduction
6.2. Services
6.2.1. Operational Imaging Services
6.2.2. Read Analysis Services
6.2.3. System & Technical Support Services
6.2.4. Trial Design & Consulting Services
6.3. Software
7. Clinical Trial Imaging Market, by Modality
7.1. Introduction
7.2. Computed Tomography
7.3. Echocardiography
7.4. Magnetic Resonance Imaging
7.5. Positron Emission Tomography
7.6. Ultrasound
7.7. X-ray
8. Clinical Trial Imaging Market, by Therapeutic area
8.1. Introduction
8.2. CVS
8.3. Endocrinology
8.4. Immunological Disorder
8.5. Infectious Diseases
8.6. Neurology
8.7. Oncology
9. Clinical Trial Imaging Market, by End-User
9.1. Introduction
9.2. Academic & Government Research Institutes
9.3. Biotechnology Companies
9.4. Contract Research Organizations
9.5. Medical Device Manufacturer
9.6. Pharmaceutical Companies
10. Americas Clinical Trial Imaging Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Clinical Trial Imaging Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Clinical Trial Imaging Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. anagram 4 clinical trials
14.2. BioClinica Inc.
14.3. Biomedical Systems Corporation
14.4. Biospective Inc.
14.5. BioTelemetry Inc.
14.6. Boston Imaging Core Lab LLC.
14.7. Calyx Group
14.8. Cardiovascular Imaging Technologies LLC.
14.9. ICON plc.
14.10. Imaging Endpoints LI, LLC
14.11. Intrinsic Imaging LLC.
14.12. IXICO plc.
14.13. Lyscaut Medical Imaging Company
14.14. Medical Metrics Inc.
14.15. Medpace Holdings, Inc.
14.16. Micron Inc.
14.17. Parexel International Corporation
14.18. Perspectum Ltd.
14.19. Pharmtrace klinische Entwicklung GmbH
14.20. Prism Clinical Imaging, Inc.
14.21. ProScan Imaging LLC.
14.22. Radiant Sage LLC.
14.23. Resonance Health Ltd.
14.24. WorldCare Clinical, LLC
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL CLINICAL TRIAL IMAGING MARKET: DYNAMICS
FIGURE 2. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2021 VS 2027 (%)
FIGURE 3. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2027
FIGURE 5. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY OPERATIONAL IMAGING SERVICES, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY OPERATIONAL IMAGING SERVICES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY READ ANALYSIS SERVICES, 2019-2027 (USD MILLION)
FIGURE 10. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY READ ANALYSIS SERVICES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 11. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY SYSTEM & TECHNICAL SUPPORT SERVICES, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY SYSTEM & TECHNICAL SUPPORT SERVICES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY TRIAL DESIGN & CONSULTING SERVICES, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY TRIAL DESIGN & CONSULTING SERVICES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY SOFTWARE, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2021 VS 2027 (%)
FIGURE 18. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2021 VS 2027 (USD MILLION)
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2027
FIGURE 20. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ECHOCARDIOGRAPHY, 2019-2027 (USD MILLION)
FIGURE 23. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ECHOCARDIOGRAPHY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2019-2027 (USD MILLION)
FIGURE 25. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2019-2027 (USD MILLION)
FIGURE 27. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ULTRASOUND, 2019-2027 (USD MILLION)
FIGURE 29. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY X-RAY, 2019-2027 (USD MILLION)
FIGURE 31. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY X-RAY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 32. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2021 VS 2027 (%)
FIGURE 33. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2021 VS 2027 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2027
FIGURE 35. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY CVS, 2019-2027 (USD MILLION)
FIGURE 36. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY CVS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 37. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ENDOCRINOLOGY, 2019-2027 (USD MILLION)
FIGURE 38. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 39. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY IMMUNOLOGICAL DISORDER, 2019-2027 (USD MILLION)
FIGURE 40. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY IMMUNOLOGICAL DISORDER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 41. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, 2019-2027 (USD MILLION)
FIGURE 42. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 43. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY NEUROLOGY, 2019-2027 (USD MILLION)
FIGURE 44. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 45. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, 2019-2027 (USD MILLION)
FIGURE 46. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 47. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 48. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2027
FIGURE 50. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, 2019-2027 (USD MILLION)
FIGURE 51. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 52. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2019-2027 (USD MILLION)
FIGURE 53. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 54. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2019-2027 (USD MILLION)
FIGURE 55. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 56. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MEDICAL DEVICE MANUFACTURER, 2019-2027 (USD MILLION)
FIGURE 57. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MEDICAL DEVICE MANUFACTURER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 58. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2019-2027 (USD MILLION)
FIGURE 59. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 60. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 75. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 76. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 77. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 78. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 79. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 80. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 81. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 82. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 83. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 84. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 85. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 86. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 87. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 88. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 89. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 90. GLOBAL CLINICAL TRIAL IMAGING MARKET: FPNV POSITIONING MATRIX
FIGURE 91. GLOBAL CLINICAL TRIAL IMAGING MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 92. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CLINICAL TRIAL IMAGING MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL CLINICAL TRIAL IMAGING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY OPERATIONAL IMAGING SERVICES, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY OPERATIONAL IMAGING SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY OPERATIONAL IMAGING SERVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY OPERATIONAL IMAGING SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY OPERATIONAL IMAGING SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY READ ANALYSIS SERVICES, BY REGION, 2019-2027 (USD MILLION)
TABLE 15. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY READ ANALYSIS SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY READ ANALYSIS SERVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY READ ANALYSIS SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY READ ANALYSIS SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY SYSTEM & TECHNICAL SUPPORT SERVICES, BY REGION, 2019-2027 (USD MILLION)
TABLE 20. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY SYSTEM & TECHNICAL SUPPORT SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY SYSTEM & TECHNICAL SUPPORT SERVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 22. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY SYSTEM & TECHNICAL SUPPORT SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY SYSTEM & TECHNICAL SUPPORT SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY TRIAL DESIGN & CONSULTING SERVICES, BY REGION, 2019-2027 (USD MILLION)
TABLE 25. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY TRIAL DESIGN & CONSULTING SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY TRIAL DESIGN & CONSULTING SERVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 27. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY TRIAL DESIGN & CONSULTING SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY TRIAL DESIGN & CONSULTING SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2019-2027 (USD MILLION)
TABLE 30. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY SOFTWARE, BY STATE, 2019-2027 (USD MILLION)
TABLE 32. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2019-2027 (USD MILLION)
TABLE 35. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2019-2027 (USD MILLION)
TABLE 36. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY STATE, 2019-2027 (USD MILLION)
TABLE 38. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ECHOCARDIOGRAPHY, BY REGION, 2019-2027 (USD MILLION)
TABLE 41. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY ECHOCARDIOGRAPHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY ECHOCARDIOGRAPHY, BY STATE, 2019-2027 (USD MILLION)
TABLE 43. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY ECHOCARDIOGRAPHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY ECHOCARDIOGRAPHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2019-2027 (USD MILLION)
TABLE 46. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY STATE, 2019-2027 (USD MILLION)
TABLE 48. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2019-2027 (USD MILLION)
TABLE 51. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY STATE, 2019-2027 (USD MILLION)
TABLE 53. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2019-2027 (USD MILLION)
TABLE 56. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY ULTRASOUND, BY STATE, 2019-2027 (USD MILLION)
TABLE 58. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY X-RAY, BY REGION, 2019-2027 (USD MILLION)
TABLE 61. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY X-RAY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 62. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY X-RAY, BY STATE, 2019-2027 (USD MILLION)
TABLE 63. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY X-RAY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY X-RAY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 65. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 66. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY CVS, BY REGION, 2019-2027 (USD MILLION)
TABLE 67. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY CVS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 68. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY CVS, BY STATE, 2019-2027 (USD MILLION)
TABLE 69. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY CVS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY CVS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 71. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2019-2027 (USD MILLION)
TABLE 72. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY ENDOCRINOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 73. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY ENDOCRINOLOGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 74. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY ENDOCRINOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY ENDOCRINOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 76. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY IMMUNOLOGICAL DISORDER, BY REGION, 2019-2027 (USD MILLION)
TABLE 77. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY IMMUNOLOGICAL DISORDER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 78. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY IMMUNOLOGICAL DISORDER, BY STATE, 2019-2027 (USD MILLION)
TABLE 79. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY IMMUNOLOGICAL DISORDER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY IMMUNOLOGICAL DISORDER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 81. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2019-2027 (USD MILLION)
TABLE 82. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 83. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, BY STATE, 2019-2027 (USD MILLION)
TABLE 84. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 86. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2019-2027 (USD MILLION)
TABLE 87. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 88. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY NEUROLOGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 89. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 91. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2019-2027 (USD MILLION)
TABLE 92. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 93. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 94. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 96. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 97. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2019-2027 (USD MILLION)
TABLE 98. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 99. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY STATE, 2019-2027 (USD MILLION)
TABLE 100. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 102. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 103. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 104. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 105. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 107. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2019-2027 (USD MILLION)
TABLE 108. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 109. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY STATE, 2019-2027 (USD MILLION)
TABLE 110. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 112. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MEDICAL DEVICE MANUFACTURER, BY REGION, 2019-2027 (USD MILLION)
TABLE 113. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY MEDICAL DEVICE MANUFACTURER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 114. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY MEDICAL DEVICE MANUFACTURER, BY STATE, 2019-2027 (USD MILLION)
TABLE 115. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY MEDICAL DEVICE MANUFACTURER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY MEDICAL DEVICE MANUFACTURER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 117. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 118. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 119. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 120. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 122. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 123. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 124. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 125. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 126. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 127. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 128. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 129. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 130. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 131. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 132. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 133. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 134. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 135. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 136. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 137. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 138. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 139. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 141. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 142. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 143. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 144. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 145. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 146. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 147. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 148. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 149. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 151. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 152. GLOBAL CLINICAL TRIAL IMAGING MARKET: SCORES
TABLE 153. GLOBAL CLINICAL TRIAL IMAGING MARKET: BUSINESS STRATEGY
TABLE 154. GLOBAL CLINICAL TRIAL IMAGING MARKET: PRODUCT SATISFACTION
TABLE 155. GLOBAL CLINICAL TRIAL IMAGING MARKET: RANKING
TABLE 156. GLOBAL CLINICAL TRIAL IMAGING MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 157. GLOBAL CLINICAL TRIAL IMAGING MARKET: MERGER & ACQUISITION
TABLE 158. GLOBAL CLINICAL TRIAL IMAGING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 159. GLOBAL CLINICAL TRIAL IMAGING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 160. GLOBAL CLINICAL TRIAL IMAGING MARKET: INVESTMENT & FUNDING
TABLE 161. GLOBAL CLINICAL TRIAL IMAGING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 162. GLOBAL CLINICAL TRIAL IMAGING MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • anagram 4 clinical trials
  • BioClinica Inc.
  • Biomedical Systems Corporation
  • Biospective Inc.
  • BioTelemetry Inc.
  • Boston Imaging Core Lab LLC.
  • Calyx Group
  • Cardiovascular Imaging Technologies LLC.
  • ICON plc.
  • Imaging Endpoints LI, LLC
  • Intrinsic Imaging LLC.
  • IXICO plc.
  • Lyscaut Medical Imaging Company
  • Medical Metrics Inc.
  • Medpace Holdings, Inc.
  • Micron Inc.
  • Parexel International Corporation
  • Perspectum Ltd.
  • Pharmtrace klinische Entwicklung GmbH
  • Prism Clinical Imaging, Inc.
  • ProScan Imaging LLC.
  • Radiant Sage LLC.
  • Resonance Health Ltd.
  • WorldCare Clinical, LLC
Note: Product cover images may vary from those shown

Loading
LOADING...